InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: north40000 post# 6478

Tuesday, 09/19/2017 5:40:01 AM

Tuesday, September 19, 2017 5:40:01 AM

Post# of 8022
north40000 I do not envision BMY/Halozyme technology to have any applications concerning $VCEL's family of autologous technologies used for Heart, CLI, as well as skin and ligament regenerative mechanisms

BMY is heavily involved in various Cancer therapies specializing in anti-PD-1/PD-L1 technologies and the possible use of other Combo drugs to enhance the destruction of those Cancers along with restoring and increasing our body's own recognition mechanisms.

Currently approx only 1 in 4 persons respond (ORR) to BMY or MRK anti-PD-1/PD-L1 FDA approved BLAs. The other 3 persons do not respond and die. Other Big Pharmas involved with anti-PD-1/PD-L1 are Roche and AZN.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News